Indefinite Delivery Contract 75N95019D00032

This Indefinite Delivery Contract (IDC) with ID 75N95019D00034 was awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. Department of Health and Human Services, to Southern Research Institute, a non-profit contract research organization. The master IDIQ contract is for CRO Support for NCATS Medicinal Chemistry for Lead Optimization, with a ceiling value of $17,891,012 and a period of performance through September 25, 2026. Under this...

The U.S. National Center for Advancing Translational Sciences (NCATS) has awarded an indefinite delivery contract (IDC) with a ceiling value of $49,885,703.00 to Purdue University to provide Chemistry, Manufacturing, and Control (CMC) services for the development of drug products. This multiple-award contract has an ultimate completion date of July 31, 2031. The scope of the contract includes a broad range of preclinical services required for the design, development, manufacture, and release...

The Department of Health and Human Services' National Center for Advancing Translational Sciences (NCATS) has issued a multiple-award Indefinite Delivery/Indefinite Quantity (IDIQ) contract valued at up to $49,885,703 to support Chemistry, Manufacturing, and Control (CMC) services for drug product development. The 7-year contract was awarded to Fisher Bioservices Inc.'s Clinical Trials Division, a subsidiary of Thermo Electron Corporation. The contract scope includes a wide range of CMC...

This indefinite delivery contract was awarded by the Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences to Mriglobal, a 501(c)(3) not-for-profit research organization, with a potential value of $49,713,679. The contract is for Chemistry, Manufacturing and Controls (CMC) and related services to support the development of drug substances for the Division of Preclinical Innovation's translational research programs. The...

The Department of Health and Human Services' National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) has awarded a single-award indefinite delivery contract to Polypeptide Laboratories San Diego, LLC, a Contract Development & Manufacturing Organization (CDMO), to provide chemistry, manufacturing, and controls (CMC) services for the development of drug substances. This five-year, $49.7 million IDV contract, awarded without set-asides, supports...

This single-award Indefinite Delivery/Indefinite Quantity (IDIQ) contract was awarded by the National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) to Concept To Market LLC, a self-certified small disadvantaged business. The contract has a potential value of $49,713,679 and a period of performance through May 14, 2031. The contract provides Chemistry, Manufacturing, and Controls (CMC) services to support the NCATS Division of Preclinical Innovation...

The National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. Department of Health and Human Services, has awarded a $48.6 million multiple-award indefinite delivery contract to conduct safety evaluation and toxicology studies in support of drug development. The contract has a 6-year ordering period and allows NCATS to issue task orders for in vitro and in vivo safety testing services, including genetic toxicology, general toxicology, and pharmacology...

The National Center for Advancing Translational Sciences (NCATS), a civilian agency, has awarded an indefinite delivery contract (IDC) worth up to $48,622,546 to Charles River Laboratories, Inc. to provide safety evaluation and toxicology studies and related services to support drug development. The contract has a period of performance from August 2024 to August 2030. Under this IDC, Charles River will perform in vitro and in vivo exploratory and Investigational New Drug (IND)-directed...

The federal contract IDV award is for Chemistry, Manufacturing, and Control (CMC) and related services to support the development of drug products for the National Center for Advancing Translational Sciences (NCATS), a civilian agency. This is a multiple award, indefinite delivery contract with a $49,885,703 ceiling value and a period of performance through July 2031. The prime contractor, Alchem Laboratories Corporation, is a for-profit pharmaceutical manufacturer that will provide a broad...

This is an indefinite-delivery/indefinite-quantity (IDIQ) contract awarded by the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences (NCATS) to Bachem Americas, Inc., a foreign-owned, for-profit manufacturer of pharmaceutical ingredients. The contract, valued up to $49.7M, is for Chemistry, Manufacturing, and Controls (CMC) services to support NCATS' drug development programs, including the production of active...